MEIRAGTX HOLDINGS PLC (MGTX) Stock Fundamental Analysis

NASDAQ:MGTX • KYG596651029

7.45 USD
+0.09 (+1.22%)
At close: Feb 13, 2026
7.45 USD
0 (0%)
After Hours: 2/13/2026, 8:24:49 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, MGTX scores 2 out of 10 in our fundamental rating. MGTX was compared to 522 industry peers in the Biotechnology industry. MGTX may be in some trouble as it scores bad on both profitability and health. MGTX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year MGTX has reported negative net income.
  • In the past year MGTX has reported a negative cash flow from operations.
  • MGTX had negative earnings in each of the past 5 years.
  • In the past 5 years MGTX always reported negative operating cash flow.
MGTX Yearly Net Income VS EBIT VS OCF VS FCFMGTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

  • With a Return On Assets value of -89.03%, MGTX is not doing good in the industry: 71.65% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -89.03%
ROE N/A
ROIC N/A
ROA(3y)-40.41%
ROA(5y)-32.41%
ROE(3y)-129.61%
ROE(5y)-91.21%
ROIC(3y)N/A
ROIC(5y)N/A
MGTX Yearly ROA, ROE, ROICMGTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

  • Looking at the Gross Margin, with a value of 41.01%, MGTX is in the better half of the industry, outperforming 73.95% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for MGTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MGTX Yearly Profit, Operating, Gross MarginsMGTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • MGTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MGTX has been increased compared to 1 year ago.
  • Compared to 5 years ago, MGTX has more shares outstanding
  • Compared to 1 year ago, MGTX has a worse debt to assets ratio.
MGTX Yearly Shares OutstandingMGTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MGTX Yearly Total Debt VS Total AssetsMGTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -8.04, we must say that MGTX is in the distress zone and has some risk of bankruptcy.
  • MGTX has a worse Altman-Z score (-8.04) than 67.24% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.04
ROIC/WACCN/A
WACC9.39%
MGTX Yearly LT Debt VS Equity VS FCFMGTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • MGTX has a Current Ratio of 0.22. This is a bad value and indicates that MGTX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.22, MGTX is not doing good in the industry: 92.15% of the companies in the same industry are doing better.
  • MGTX has a Quick Ratio of 0.22. This is a bad value and indicates that MGTX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MGTX has a Quick ratio of 0.22. This is amonst the worse of the industry: MGTX underperforms 91.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
MGTX Yearly Current Assets VS Current LiabilitesMGTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The earnings per share for MGTX have decreased by -2.93% in the last year.
  • Looking at the last year, MGTX shows a very strong growth in Revenue. The Revenue has grown by 96.83%.
  • Measured over the past years, MGTX shows a very strong growth in Revenue. The Revenue has been growing by 20.15% on average per year.
EPS 1Y (TTM)-2.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.73%
Revenue 1Y (TTM)96.83%
Revenue growth 3Y-4.07%
Revenue growth 5Y20.15%
Sales Q2Q%-96.24%

3.2 Future

  • MGTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.15% yearly.
  • Based on estimates for the next years, MGTX will show a very strong growth in Revenue. The Revenue will grow by 90.13% on average per year.
EPS Next Y-3.92%
EPS Next 2Y17.64%
EPS Next 3Y16.32%
EPS Next 5Y14.15%
Revenue Next Year94.29%
Revenue Next 2Y260.66%
Revenue Next 3Y118.38%
Revenue Next 5Y90.13%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MGTX Yearly Revenue VS EstimatesMGTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
MGTX Yearly EPS VS EstimatesMGTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • MGTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MGTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGTX Price Earnings VS Forward Price EarningsMGTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGTX Per share dataMGTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • MGTX's earnings are expected to grow with 16.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.64%
EPS Next 3Y16.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MGTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MEIRAGTX HOLDINGS PLC

NASDAQ:MGTX (2/13/2026, 8:24:49 PM)

After market: 7.45 0 (0%)

7.45

+0.09 (+1.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13
Earnings (Next)03-12
Inst Owners49.16%
Inst Owner Change4.91%
Ins Owners4.16%
Ins Owner Change10.48%
Market Cap599.65M
Revenue(TTM)27.42M
Net Income(TTM)-168.69M
Analysts84.29
Price Target27.92 (274.77%)
Short Float %11.06%
Short Ratio11.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.36%
Min EPS beat(2)-24.05%
Max EPS beat(2)-0.66%
EPS beat(4)1
Avg EPS beat(4)-3.75%
Min EPS beat(4)-24.05%
Max EPS beat(4)12.47%
EPS beat(8)2
Avg EPS beat(8)-41.18%
EPS beat(12)4
Avg EPS beat(12)-30.49%
EPS beat(16)5
Avg EPS beat(16)-24.85%
Revenue beat(2)0
Avg Revenue beat(2)-74.5%
Min Revenue beat(2)-94.22%
Max Revenue beat(2)-54.78%
Revenue beat(4)1
Avg Revenue beat(4)272.91%
Min Revenue beat(4)-94.22%
Max Revenue beat(4)1298.04%
Revenue beat(8)2
Avg Revenue beat(8)173.75%
Revenue beat(12)3
Avg Revenue beat(12)102.95%
Revenue beat(16)6
Avg Revenue beat(16)103.42%
PT rev (1m)-0.45%
PT rev (3m)-0.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.06%
Revenue NQ rev (1m)17.87%
Revenue NQ rev (3m)-75.62%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-62.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.87
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.11
EYN/A
EPS(NY)-1.31
Fwd EYN/A
FCF(TTM)-1.5
FCFYN/A
OCF(TTM)-1.44
OCFYN/A
SpS0.34
BVpS-0.5
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -89.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.01%
FCFM N/A
ROA(3y)-40.41%
ROA(5y)-32.41%
ROE(3y)-129.61%
ROE(5y)-91.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.18%
Cap/Sales 17.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -8.04
F-Score4
WACC9.39%
ROIC/WACCN/A
Cap/Depr(3y)233.72%
Cap/Depr(5y)368.57%
Cap/Sales(3y)147.08%
Cap/Sales(5y)142.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.73%
EPS Next Y-3.92%
EPS Next 2Y17.64%
EPS Next 3Y16.32%
EPS Next 5Y14.15%
Revenue 1Y (TTM)96.83%
Revenue growth 3Y-4.07%
Revenue growth 5Y20.15%
Sales Q2Q%-96.24%
Revenue Next Year94.29%
Revenue Next 2Y260.66%
Revenue Next 3Y118.38%
Revenue Next 5Y90.13%
EBIT growth 1Y7.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.57%
OCF growth 3YN/A
OCF growth 5YN/A

MEIRAGTX HOLDINGS PLC / MGTX FAQ

Can you provide the ChartMill fundamental rating for MEIRAGTX HOLDINGS PLC?

ChartMill assigns a fundamental rating of 2 / 10 to MGTX.


What is the valuation status for MGTX stock?

ChartMill assigns a valuation rating of 0 / 10 to MEIRAGTX HOLDINGS PLC (MGTX). This can be considered as Overvalued.


Can you provide the profitability details for MEIRAGTX HOLDINGS PLC?

MEIRAGTX HOLDINGS PLC (MGTX) has a profitability rating of 1 / 10.


Can you provide the financial health for MGTX stock?

The financial health rating of MEIRAGTX HOLDINGS PLC (MGTX) is 0 / 10.